Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2013. The document serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding the GlaxoSmithKline US Deferred Performance Share Plan.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction where Mr. D E Troy acquired 277.246 ADSs at a price of $50.84 per ADS following the re-investment of a dividend paid on October 3, 2013.
Key Facts for Investors
- Transaction Type: Increase in director interests via dividend re-investment.
- Individual Involved: Mr. D E Troy.
- Shares Acquired: 277.246 ADSs.
- Transaction Price: $50.84 per ADS.
- Dividend Date: October 3, 2013.
- Reporting Date: October 9, 2013.